Genetic Stock Analysis

GENE -  USA Stock  

USD 4.11  0.03  0.72%

Genetic Tech price dip over the last few months may raise some interest from shareholders. The stock closed today at a share price of 4.11 on 91,736 in trading volume. The company executives were not very successful in positioning the firm resources to exploit market volatility in May. However, diversifying your holdings with Genetic Tech Spn or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.19. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Genetic Tech Spn partners.
Please check Risk vs Return Analysis.

Search Stock Analysis 

 
Refresh
The Genetic Tech stock analysis report makes it easy to digest most publicly released information about Genetic Tech and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Genetic stock analysis module also helps to analyze the Genetic Tech price relationship with some important fundamental indicators such as market cap and management efficiency.

Genetic Stock Analysis Notes

The book value of the company was currently reported as 1.2. The company recorded a loss per share of 0.6. Genetic Tech Spn had not issued any dividends in recent years. The entity had 1:5 split on the 15th of August 2019. Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage womens health in Australia and the United States. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia. Genetic Tech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. To learn more about Genetic Tech Spn call Eutillio Buccilli at 61 3 8412 7000 or check out http://www.gtglabs.com.

Genetic Tech Quarterly Deferred Revenue

0.0Share

Genetic Tech Spn Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Genetic Tech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Genetic Tech Spn or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Genetic Tech Spn generates negative expected return over the last 90 days
Genetic Tech Spn has high historical volatility and very poor performance
Genetic Tech Spn has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 25.71 K. Net Loss for the year was (6.93 M) with loss before overhead, payroll, taxes, and interest of (241.65 K).
Genetic Tech Spn currently holds about 16.44 M in cash with (6.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19.
Genetic Tech Spn has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Genetic Tech Spn Ads falls 3.54 percent for May 24 - Equities.com

Genetic Tech SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Genetic Tech prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Genetic Tech investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Genetic Tech Spn specific information freely available to individual and institutional investors to make a timely investment decision.

Genetic Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Genetic Tech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genetic Tech Spn backward and forwards among themselves. Genetic Tech's institutional investor refers to the entity that pools money to purchase Genetic Tech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Citadel Advisors LlcCommon Shares105 K438 K
Susquehanna International Group LlpCommon Shares67.5 K282 K
Susquehanna Fundamental Investments LlcCommon Shares64.6 K269 K
Susquehanna International Group LlpPut Options52.4 K219 K
Group One Trading LpCommon Shares48.8 K204 K
Citadel Advisors LlcCall Options31.1 K130 K
Simplex Trading LlcCommon Shares26.9 K112 K
Two Sigma Securities LlcCommon Shares23.7 K99 K
Goldman Sachs Group IncCommon Shares21.6 K90 K
Note, although Genetic Tech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Genetic Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 78.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genetic Tech's market, we take the total number of its shares issued and multiply it by Genetic Tech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Genetic Profitablity

Genetic Tech's profitability indicators refer to fundamental financial ratios that showcase Genetic Tech's ability to generate income relative to its revenue or operating costs. If, let's say, Genetic Tech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genetic Tech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genetic Tech's profitability requires more research than a typical breakdown of Genetic Tech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.58) (0.63) 
Return on Average Equity(0.74) (0.80) 
Return on Invested Capital(12.49) (13.47) 
Return on Sales(555.12) (569.73) 

Management Efficiency

The entity has return on total asset (ROA) of (45.42) % which means that it has lost $45.42 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (68.1) %, meaning that it created substantial loss on money invested by shareholders. Genetic Tech management efficiency ratios could be used to measure how well genetic tech spn manages its routine affairs as well as how well it operates its assets and liabilities. As of June 17, 2021, Return on Average Assets is expected to decline to -0.63. In addition to that, Return on Average Equity is expected to decline to -0.8. Genetic Tech Goodwill and Intangible Assets are projected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 547,629. The current year Asset Turnover is expected to grow to 0.000924, whereas Current Assets are forecasted to decline to about 14.2 M.
Last ReportedProjected for 2021
Book Value per Share 1.69  1.74 
Enterprise Value over EBIT(1.80) (1.85) 
Enterprise Value over EBITDA(1.96) (2.01) 
Price to Book Value 1.12  1.15 
Tangible Assets Book Value per Share 2.03  2.08 
Enterprise Value8.2 M12.8 M
Tangible Asset Value18 M15.3 M

Technical Drivers

As of the 17th of June 2021, Genetic Tech retains the risk adjusted performance of (0.014339), and Market Risk Adjusted Performance of (1.07). Genetic Tech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Genetic Tech Spn, which can be compared to its competitors. Please check out Genetic Tech Spn maximum drawdown, and the relationship between the information ratio and downside variance to decide if Genetic Tech is priced fairly, providing market reflects its last-minute price of 4.11 per share. Given that Genetic Tech Spn has jensen alpha of (0.17), we strongly advise you to confirm Genetic Tech Spn's regular market performance to make sure the company can sustain itself at a future point.

Genetic Tech Spn Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Genetic Tech Spn more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Genetic Tech Predictive Daily Indicators

Genetic Tech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genetic Tech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Genetic Tech Forecast Models

Genetic Tech time-series forecasting models is one of many Genetic Tech's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genetic Tech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Genetic Tech Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Genetic Tech stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genetic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Genetic Tech. By using and applying Genetic Stock analysis, traders can create a robust methodology for identifying Genetic entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(25.85) (26.53) 
Gross Margin(22.05) (22.63) 
Profit Margin(25.98) (26.66) 
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage womens health in Australia and the United States. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia. Genetic Tech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genetic Tech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Please check Risk vs Return Analysis. Note that the Genetic Tech Spn information on this page should be used as a complementary analysis to other Genetic Tech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Genetic Tech Stock analysis

When running Genetic Tech Spn stock analysis, check to measure Genetic Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Tech is operating at the current time. Most of Genetic Tech's stock examination focuses on studying past and present price action to predict the probability of Genetic Tech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Genetic Tech's price. Additionally, you may evaluate how the addition of Genetic Tech to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
The market value of Genetic Tech Spn is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Tech stock's value that differs from its market value or its book value, called intrinsic value, which is Genetic Tech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Tech's market value can be influenced by many factors that don't directly affect Genetic Tech Spn underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Tech's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Genetic Tech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Tech's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.